These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1292217)

  • 1. [The efficacy of immunomodulating preparations in treating patients with chronic cholestatic liver diseases].
    Radchenko VG; Mitrofanova TI; Serebriakova VI; Vinogradova GL
    Lik Sprava; 1992; (11-12):38-41. PubMed ID: 1292217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
    Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
    Sov Med; 1990; (6):111-3. PubMed ID: 2144365
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
    Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
    Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy of immunomodulating therapy in patients with chronic cholestatic liver diseases].
    Petrunia AM; Enenko IuA
    Lik Sprava; 1996; (3-4):125-7. PubMed ID: 9035846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary immunodeficiency and its correction with thymus preparations in patients with postabortion endometritis].
    Franchuk AE; Benzar ZT
    Akush Ginekol (Mosk); 1990 Sep; (9):40-3. PubMed ID: 2278306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
    Ivanova LA
    Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
    Balabolkin MI; Arion VIa; Petunina NA
    Sov Med; 1987; (12):32-5. PubMed ID: 3502197
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
    Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
    Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
    [No Abstract]   [Full Text] [Related]  

  • 11. [The electrophoretic mobility of peripheral blood lymphocytes in patients with tuberculosis of the lungs].
    Skvortsova RG; Nikitina OI
    Probl Tuberk; 1990; (5):11-4. PubMed ID: 2388887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic liver diseases: secondary thymic insufficiency and immunocorrection with T-activin].
    Sarkisian SV
    Klin Med (Mosk); 1994; 72(6):45-8. PubMed ID: 7898010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the effectiveness of immunomodulating preparations in combined therapy of chronic obstructive bronchitis].
    Shilov VA; Shirinskiĭ VS
    Klin Med (Mosk); 1995; 73(4):88-90. PubMed ID: 7474838
    [No Abstract]   [Full Text] [Related]  

  • 14. [The validation of the use of thymic preparations in tuberculous infection by experimental data].
    Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
    Vrach Delo; 1991 May; (5):53-5. PubMed ID: 1866916
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients].
    Ianiushina VV
    Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals].
    Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
    Probl Tuberk; 1991; (12):52-4. PubMed ID: 1803376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary autoimmune syndrome and immunomodulating lymphotropic therapy in acute pancreatitis].
    Zaĭrat'iants OV; Kolobov SV; Iarema IV; Shevchenko VP
    Arkh Patol; 2002; 64(6):51-6. PubMed ID: 12534231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T-cell immunity and immunomodulators in the comprehensive treatment of diffuse toxic goiter].
    Petunina NA; Balabolkin MI; Arion VIa
    Ross Med Zh; 1992; (5-12):19-24. PubMed ID: 1286263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for using thymalin in the therapy of children with chronic viral hepatitis B].
    Gol'zand IV; Goriacheva LG; Volkov VO; Khavinson VKh; Morozov VG
    Voen Med Zh; 1986 Mar; (3):27-8. PubMed ID: 3487166
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of the effectiveness of immunomodulators in the treatment of patients with postoperative suppurative-septic complications].
    Bulava GV; Nikulina VP
    Khirurgiia (Mosk); 1996; (2):104-7. PubMed ID: 8754918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.